A time-course design (0–240 min) combined commercial papain versus bromelain treatment with UPLC-HRMS metabolite profiling to ...
Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to demonstrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results